Coding Essentials for Laboratories 2017
|
|
|
- Darrell Britton King
- 6 years ago
- Views:
Transcription
1 Coding Essentials for Laboratories 2017 An Easy-to-Use Tool for Coding and Reimbursement Compliance Prepared and Published By: MedLearn Publishing A Division of Panacea Healthcare Solutions, Inc. 287 East Sixth Street, Suite 400 St. Paul, MN panaceainc.com
2 Introduction... 1 New Way of Thinking...1 Future of Reimbursement...2 CPT Coding Guidelines...3 CPT Terminology Format...4 Coding Flowcharts...5 Quantitative vs. Qualitative...5 Specimen Codes...6 Each Specimen or Each Analyte...7 Free and Total Studies...8 Only and Screen Tests...9 Each Antigen or Each Antibody...10 Antigens or Antibodies...11 With or Without Studies...11 In Addition Studies...12 Category III CPT Codes...12 HCPCS Alternate Codes...13 Revenue Center Codes...14 Modifiers...15 National Correct Coding Initiative...19 Procedure-to-Procedure Edits...20 Add-on Edits...21 Medically Unlikely Edits...22 Other Coding Guidance...23 National Coverage Determinations...23 Local Coverage Determinations...25 Routine Screening Tests...25 Reasonable and Necessary Denials...26 Frequency Limits...26 Tests Not Ordered by Qualified Provider...26 Diagnosis Coding Guidelines for Labs...26 ICD-10 Coding Primer...27 The ICD-10 Coding System...28 Stay Informed...29 CLIA Compliance...29 Medicare Packaging of Lab Tests...29 i
3 Chapter 1: Organ and Disease Panels Standard and Custom Panels...31 Screening Tests...31 Duplicate Billing...32 ESRD Composite Rate Billing...32 Organ or Disease-Oriented Panels...33 Billing and Coding Tips...33 Coding Changes for Chapter 2: Drug Testing Drugs of Abuse Analysis...35 Presumptive Drug Analysis...36 Reporting of Presumptive Drug Analysis...36 Definitive Drug Analysis...37 Reporting of Definitive Drug Analysis...37 Opioids and Opiate Analogs...38 Billing and Coding Tips...40 Coding Changes for Chapter 3: Therapeutic Drug Assays Multiple Tests...43 Unlisted Tests...44 Billing and Coding Tips...45 Coding Changes for Chapter 4: Urinalysis Routine Urinalysis...47 Other Urinalysis...48 Coding Flowchart...49 Billing and Coding Tips...50 Coding Changes for Chapter 5: Molecular Pathology Professional Interpretation...55 Geonomic Sequencing Procedures and Other Molecular Analyte Assays...55 Multianalyte Algorithmic Assay...56 ii
4 Payment...57 Coding Changes for Chapter 6: Chemistry Testing Custom Profiles and Panels...71 Comprehensive Codes...71 When the Specimen Matters...72 When the Method Matters...72 Frequency Limits and Overutilization...73 Example: Blood Glucose Testing...74 Billing and Coding Tips...75 Coding Changes for Chapter 7: Hematology Standardized Chargemaster for Multisite Facilities...77 Customizing Test Descriptions...77 Chargemaster-Driven Overutilization...78 Compliance Issues...78 Reflex Testing vs. Quality Assurance...78 Prescription Pad Orders...79 Coding Flowchart...81 Billing and Coding Tips...82 Coding Changes for Chapter 8: Coagulation Testing Custom Profiles and Panels...83 Medical Necessity Versus Screening...83 Standing Orders Versus Recurring Orders...83 Frequency Limits and Overutilization...84 Coding Flowchart...85 Billing and Coding Tips...85 Coding Changes for Chapter 9: Immunology Compliance Issues...88 Reflex Testing...88 iii
5 NCCI and Medically Unlikely Edits...88 Authoritative Resources...89 Billing and Coding Tips...90 Coding Changes for Chapter 10: Microbiology Matching the Requisition to the Chargemaster...93 Submitting Follow-up Test Codes...94 Culture of Pathogen and Detection of Infectious Agent...95 Infectious Antigen Detection...97 To Recap the Issues...98 Coding Flowchart Billing and Coding Tips Coding Changes for Chapter 11: Blood Banking and Transfusion Medicine Billing for the Blood Product Crossmatch Codes Retyping the Units Code Assignment for Transfusion Medicine Services Blood Transfusions Billing and Coding Tips Coding Changes for Chapter 12: Cytopathology Non-Gynecological Specimens CPT/HCPCS Codes Intended Use of Codes Billing and Coding Tips Gynecological Specimens CPT/HCPCS Codes Intended Use of Codes Billing and Coding Tips Coding Changes for Fine Needle Aspirate iv
6 CPT/HCPCS Codes Intended Use of Codes Billing and Coding Tips Coding Changes for Flow Cytometry CPT/HCPCS Codes Billing and Coding Tips Coding Changes for Chapter 13: Cytogenetic Studies Coding Flowchart Billing and Coding Tips Coding Changes for Chapter 14: Surgical Pathology and Histology Outpatient Payment and APCs Unit of Service Date of Service Rules for Histology Specimen Processing, Special Stains and Other Related Procedures Billing and Coding Tips Frozen Section CPT/HCPCS Codes Intended Use of Codes Billing and Coding Tips Touch Prep CPT/HCPCS Codes Intended Use of Codes Billing and Coding Tips Antibody Techniques CPT/HCPCS Codes Intended Use of Codes Billing and Coding Tips Bone Marrow Studies Prostate Biopsy Mapping Specimens Morphometric Analysis v
7 CPT/HCPCS Codes Intended Use of Codes Billing and Coding Tips Nerve Teasing CPT/HCPCS Codes Intended Use of Codes Billing and Coding Tips In situ Hybridization CPT/HCPCS Codes Intended Use of Codes Billing and Coding Tips Protein Analysis of Tissue by Western Blot CPT/HCPCS Codes Intended Use of Codes Billing and Coding Tips Dissection and Microdissection Procedures CPT/HCPCS Codes Intended Use of Codes Billing and Coding Tips Postmortem Examination CPT/HCPCS Codes Intended Use of Codes Billing and Coding Tips Coding Changes for vi
8 Chapter 15: In Vivo (Transcutaneous) Procedures, Miscellaneous Testing, Reproductive Medicine Handling or Shipping Fees In Vivo (Transcutaneous) Procedures Specimen Collection (Venipunctures, Finger-sticks and Arterial Punctures) Travel Allowance Billing and Coding Tips Coding Changes for Chapter 16: Preventive Screening Procedures Prostate Antigen Screening for Adenocarcinoma Fecal Occult Blood Screening for Colorectal Cancer Measurement of Lipid Levels to Screen for Cardiovascular Disease Diabetes Screening Human Immunodeficiency Virus Sexually Transmitted Infections (STIs) Hepatitis C Virus Screening Billing and Coding Tips Chapter 17: Payment Methods for Clinical Laboratory and Professional Services Pathology Payment Methods Column 1: HCPCS Column 2: Mod (Modifier) Column 3: MPFS Status Code Column 4: MPFS PC/TC Indicator Column 5: MPFS Work RVU Column 6: MPFS Facility RVU Column 7: Non-Facility RVU Column 8: MPFS Conversion Factor Column 9: OPPS Status Indicator Column 10: OPPS APC Rate Column 11: CLFS National Limit vii
9 Clinical Pathology Consultations Consultations on Referred Material Appendix A: Medicare Manuals Appendix B: Medicare Quality Payment Programs Hospital IQR Program Hospital OQR Program Beyond the IQR and OQR Programs viii
Coding Essentials for Infusion and Injection Therapy Services 2018
Coding Essentials for Infusion and Injection Therapy Services 2018 A guide for outpatient injections, non-chemotherapy and chemotherapy administration services Prepared and Published By: MedLearn Publishing
CAP Accreditation Checklists 2017 Edition
CAP Accreditation Checklists 2017 Edition The College of American Pathologists (CAP) accreditation checklists contain the CAP accreditation program requirements, developed on more than 50 years of insight
MND Review of Molecular and Genomic Diagnostic Testing Services Questions & Answers
MND Review of Molecular and Genomic Diagnostic Testing Services Questions & Answers 1. What is the Molecular and Genomic Testing Program? Horizon Blue Cross Blue Shield of New Jersey has expanded its collaboration
HFMA Western NY Chapter January 25, 2011 Day OPPS UPDATES, CODING CHANGES AND CHARGE MASTER APPROACHES
HFMA Western NY Chapter January 25, 2011 Day 1 2011 OPPS UPDATES, CODING CHANGES AND CHARGE MASTER APPROACHES INTRODUCTIONS Caroline Rader, Associate Director Ms. Rader has approximately 15 years combined
Chargemaster Fundamentals for a Solid Revenue Cycle Foundation. November 7, 2012 John Behn
Chargemaster Fundamentals for a Solid Revenue Cycle Foundation Understanding the Importance, Purpose and Function of your Charge Data Master November 7, 2012 John Behn National Rural Health Resource Center
Laboratory Tests Chronic Renal Deficiency (CRD) Patients (NCD )
Policy Number 190.10 Approved By UnitedHealthcare Medicare Reimbursement Policy Committee Current Approval Date 03/26/2014 IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY This policy is applicable to UnitedHealthcare
Coding Laboratory Services
Audio Seminar/Webinar June 4, 2009 Practical Tools for Seminar Learning Copyright 2009 American Health Information Management Association. All rights reserved. Disclaimer The American Health Information
ANTHEM BLUE CROSS REIMBURSEMENT POLICIES AND MCKESSON CLAIMSXTEN RULES
ANTHEM BLUE CROSS REIMBURSEMENT POLICIES AND MCKESSON CLAIMSXTEN RULES Overview This document provides all new, revised and existing Policies and all new, revised and existing claims editing rules administered
Making the business of healthcare easier. Don t Have a Clue About the CDM? It s Elementary, Watson! HFMA LONE STAR SUMMER INSTITUTE August 18, 2017
Making the business of healthcare easier. Don t Have a Clue About the CDM? It s Elementary, Watson! HFMA LONE STAR SUMMER INSTITUTE August 18, 2017 Follow us on LinkedIn for details on future webinars,
MEDICAL LABORATORY SCIENCE (MLS)
MEDICAL LABORATORY SCIENCE (MLS) Explanation of Course Numbers Courses in the 1000s are primarily introductory undergraduate courses Those in the 2000s to 4000s are upper-division undergraduate courses
$29.00 $30.00 Blood Glucose Testing (190.20) (Also see Medicare Preventative Services Quick Reference) Carcinoembryonic Antigen (CEA) (190.
TEST DESCRIPTION INCLUDES TESTS NATIONAL COVERAGE DETERMINATIONS (NCD S) Est. cost Alpha Fetoprotein (190.25) 82105 alpha-fetoprotein, serum $35.96 Blood Counts (CBC) (190.15) 85004 -- Blood count; automated
GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS
GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS 1. Introduction 1.1 This document provides guidance notes for the assessment of academic qualifications that have not been formally accredited
Renal Dialysis Services
INDIANA HEALTH COVERAGE PROGRAMS PROVIDER REFERENCE M ODULE Renal Dialysis Services L I B R A R Y R E F E R E N C E N U M B E R : P R O M O D 0 0 0 4 5 P U B L I S H E D : N O V E M B E R 1 6, 2 0 1 7
Update on the IVDR. Sue Spencer
Update on the IVDR Sue Spencer Caution The new regulations are draft the principles have now been agreed but the Annexes are subject to minor changes Further details will be added later pre and post application
CHARGE DESCRIPTION MASTER (CDM)
CHARGE DESCRIPTION MASTER (CDM) Facility Best Practices and How to Sustain Robert M. Gilbert, FHFMA, COC Senior Manager, Healthcare Consulting DISCLAIMER This presentation is for general education purposes
American Society of Cytopathology Core Curriculum in Molecular Biology
American Society of Cytopathology Core Curriculum in Molecular Biology American Society of Cytopathology Core Curriculum in Molecular Biology Chapter 4 Stephanie A. Hamilton, EdD, SCT, MB(ASCP) CM MD Anderson
Berkeley Medical Center Jefferson Medical Center Laboratory Directory
Berkeley Medical Center Jefferson Medical Center Laboratory Directory - 2017 Test Procedures, Specimen Requirements and Instructions February 2017 1 TABLE OF CONTENTS Laboratory Information..3 General
Charge Capture: What You Don t Know IS Killing You!
Charge Capture: What You Don t Know IS Killing You! Kauser Karwa MBA, RHIA, CDIP Manager McGladrey Bob Medcalf CEO Net Revenue Associates May 14, 2015 Objectives 1. Gain a broad level understanding on
PHYSICIAN OFFICE BILLING INFORMATION SHEET FOR IMLYGIC (talimogene laherparepvec)
PHYSICIAN OFFICE BILLING INFORMATION SHEET FOR IMLYGIC (talimogene laherparepvec) INDICATION IMLYGIC is a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable
BIOMEDICAL SCIENCE (BMS)
University of New Hampshire 1 BIOMEDICAL SCIENCE (BMS) # Course numbers with the # symbol included (e.g. #400) have not been taught in the last 3 years. BMS 401 - Professional Perspectives in Biomedical
Roche, Roche Molecular Diagnostics and more
, Molecular and more [Monte Wetzel, PhD] Patients have questions. We provide answers. Group Clear focus on Healthcare Innovation with two strong pillars Pharma Pharma Genentech Chugai Molecular Professional
College of Physicians and Surgeons of Saskatchewan Laboratory Quality Assurance Program. Policy Manual Edition
College of Physicians and Surgeons of Saskatchewan Laboratory Quality Assurance Program Policy Manual 2016 Edition LABORATORY QUALITY ASSURANCE POLICY MANUAL SUMMARY OF POLICY MANUAL CHANGES The following
Aligning Lab Goals & Institutional Goals Laughlin Rice
Aligning Lab Goals & Institutional Goals Laughlin Rice Senior Administrative Director Department of Pathology & Laboratory Medicine The Children s Hospital of Learning Objectives To understand the institutional
Lecture 23: Clinical and Biomedical Applications of Proteomics; Proteomics Industry
Lecture 23: Clinical and Biomedical Applications of Proteomics; Proteomics Industry Clinical proteomics is the application of proteomic approach to the field of medicine. Proteome of an organism changes
Transgender Fundamentals for Health Care Practitioners Course # / 1.0 credit hours
Transgender 101 - Fundamentals for Health Care Practitioners Course # 612-405-17 / 1.0 credit hours Paula Neira, JD, MSN, RN, CEN Clinical Program Director Center for Transgender Health Johns Hopkins Health
FLORIDA WORKERS COMPENSATION HEALTH CARE PROVIDER REIMBURSEMENT MANUAL Edition
FLORIDA WORKERS COMPENSATION HEALTH CARE PROVIDER REIMBURSEMENT MANUAL 2008 Edition Department of Financial Services Florida Department of Financial Services Division of Workers Compensation for incorporation
Physician Office Billing & Payment Guide
Physician Office Billing & Payment Guide Dermal Regeneration Matrix Dermal Repair Scaffold Ag Antimicrobial Dermal Repair Scaffold Physician Office Billing & Payment Guide Billing and Medicare Payment
Classification under the IVD Regulation
Classification under the IVD Regulation Nick Baker Head of IVD Notified Body LRQA Ltd Improving performance, reducing risk IVD regulation shift in regulatory scrutiny Under the current IVD directive 10-15%
TECHNOLOGIES & SERVICES FOR THERAPEUTIC ANTIBODY DEVELOPMENT
Specialist in tissue analysis by Histology, Immunohistochemistry and In Situ Hybridization TECHNOLOGIES & SERVICES FOR THERAPEUTIC ANTIBODY DEVELOPMENT CONTENTS Histalim: who we are Our areas of expertise
EvaluateMedTech has used a number of sources within the site to develop a 4-level classification tree based on the FDA approvals process.
Classification of Approvals from Devices@FDA FDA Classification EvaluateMedTech has used a number of sources within the Devices@FDA site to develop a 4-level classification tree based on the FDA approvals
Annual Charge Master Update
Annual Charge Master Update Best Practices to Start Off the New Year Right Jon Menard, CPC, COC, CRCR Consulting Manager The ROI Companies Agenda Charge Description Master (CDM) Management structure &
Multianalyte Assays with Algorithmic Analyses (MAAA)
Mr. Glenn McGuirk Centers for Medicare and Medicaid Services 7500 Security Blvd. Baltimore, Maryland 21244 Docket # CMS-1441-N Dear Mr. McGuirk: The American Association for Clinical Chemistry (AACC) welcomes
Bachelor of Science (Hons) / Bachelor of Science Biomedical Science
Bachelor of Science (Hons) / Bachelor of Science Biomedical Science Awarded by In collaboration with This degree course is designed to give you a broad understanding of the scientific investigation of
HOW TO WRITE A REQUEST FOR PROPOSAL FOCUSING ON A VALUE-BASED MODEL
HOW TO WRITE A REQUEST FOR PROPOSAL FOCUSING ON A VALUE-BASED MODEL A well-designed proposal can be the difference between an accurate and clear view of a reference laboratory partner and a lengthy document
Calendar Year 2018 Medicare Hospital Outpatient Prospective Payment System Proposed Rule
Calendar Year 2018 Medicare Hospital Outpatient Prospective Payment System Proposed Rule August 2017 This document is presented for informational purposes only and is not intended to provide reimbursement
Histocompatibility. Revised and effective July 14, Histocompatibility Standard 1 (HC S1)
Clinical Laboratory s of Practice The following specialty sustaining standards of practices shall be incorporated into the laboratory s quality management system, where applicable to the scope of services
European Regulatory Experiences and Expectations of HCP Analysis and Control
HCP Strategy Forum, Washington DC, January 26, 2015 www.pei.de European Regulatory Experiences and Expectations of HCP Analysis and Control Blood Products: Dr. Erika Friedl, PEI (DE) Discalimer: The views
Partnering & Networks
Partnering & Networks Success drivers in an ever changing and complex health care system Dr. Benedikt Hoffmann, Senior Manger New Business Development & J&J Innovation Manager October 2 nd, 2014 Judith
HIGH SCHOOL STUDENT SCIENCE WEEK. St. Paul s Hospital Vancouver, BC
HIGH SCHOOL STUDENT SCIENCE WEEK St. Paul s Hospital Vancouver, BC Sponsors 2 AGENDA Location: UBC James Hogg Research Centre (JHRC), St. Paul s Hospital, Room 166 Burrard Building, 1081 Burrard Street,
1001 NW Technology Drive, Lee's Summit, MO // (800) // (816) Fax //
Herpes Simplex Virus 1 & 2 (HSV-1 & HSV-2) Quantitative Real-time PCR Test Code: 8500 Some specimen types for this assay are reported as qualitative results; please see our Specimen Information section
Billing Contact: Phone: Research Funding: NIH Funded Industry Funded Department Funded Short Study Protocol Title:
Please submit this application to CPRS@mednet.ucla.edu at least 2-3 weeks prior to the beginning of the research for approval. All UCLA studies using patient medical record numbers/identifiers must be
FAQ ABOUT. 21CFR Part 1271 FDA REGULATION OF REPRODUCTIVE TISSUE LABS
FAQ ABOUT 21CFR Part 1271 FDA REGULATION OF REPRODUCTIVE TISSUE LABS XYTEX INTERNATIONAL, LTD. AUGUSTA, GEORGIA NOVEMBER 2005 Xytex International, 2005 Xytex is a registered trademark of Xytex International,
Provider Memorandum National Drug Code (NDC) Billing Guidelines
September 15, 2017 Provider Memorandum National Drug Code (NDC) Billing Guidelines As a result to changes in the Public Act 097-0689, referred to as the Save Medicaid Access and Resources Together (SMART
Strategies to Reduce Pharmacy Claims Denials
Strategies to Reduce Pharmacy Claims Denials Pharmacy OneSource Webinar Ellen Fan, R.Ph. Clinical Financial Analysis Pharmacist Corporate Pharmacy December 16, 2010 Objectives Describe steps taken to create
How To Respond To An Audit. Guillermo Beades, Esq.
How To Respond To An Audit Guillermo Beades, Esq. The Audit Process The Audit Process Risk Factors What factors put practices at increased risk for an audit? Disgruntled employees Dissatisfied patients
SYSTEM POLICY AND PROCEDURES
CATEGORY Compliance EFFECTIVE DATE November 3, 1999 REVISED October 31, 2002 INDEX PAGE 1 of 6 SYSTEM POLICY AND PROCEDURES SUBJECT: SCOPE: AUTHORIZATION: Baptist Healthcare System Service Item Master
THE ESSENTIAL ELEMENT of a
THE ESSENTIAL ELEMENT of a Successful Laboratory LabDAQ Laboratory Information System (LIS) is a scalable SOLUTION trusted by thousands of physicians and laboratory professionals every day. Experience
AAG PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE
IMMAGE Immunochemistry Systems Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Alpha 1 -Acid Glycoprotein REF 447780 (150 tests) For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by:
The Comments Are In: Stakeholders Categorize Genomic Tests
Commercializing Stem Cell-Based Therapies: Meeting NIH and FDA Requirements The Comments Are In: Stakeholders Categorize Genomic Tests September 2012 Bruce Quinn MD PhD Senior Health Policy Specialist
AMBULANCE POLICY. Policy Number: TRANSPORTATION T0 Effective Date: January 1, Related Policies None
AMBULANCE POLICY UnitedHealthcare Oxford Reimbursement Policy Policy Number: TRANSPORTATION 004.15 T0 Effective Date: January 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE LINES OF
MEDICAL BILLING ASSOCIATE
MEDICAL BILLING ASSOCIATE Position Description: Responsible for functions of the medical billing and coding office to ensure maximization of cash flow while improving patient, physician, and other customer
North Carolina Medicaid Special Bulletin
North Carolina Medicaid Special Bulletin An Information Service of the Division of Medical Assistance Visit DMA on the Web at http://www.ncdhhs.gov/dma December 2014 Attention: All Providers Modifier 59
National Drug Codes Requirement for UnitedHealthcare Community Plan. Calculating the Appropriate Number of National Drug Code (NDC) Units
National Drug Codes Requirement for UnitedHealthcare Community Plan Calculating the Appropriate Number of National Drug Code (NDC) Units National Drug Code Requirement Effective for claims with a date
2018 Resources for Health Care Delivery Organizations
AMA HEALTH SOLUTIONS 2018 Resources for Health Care Delivery Organizations Health Care Delivery Organizations Toolkit for Counting Users & FAQs September 2017 User Proxy Model Calculator for data file
Notice of Faculty Disclosure
Pathologist Extenders: Current and Future Amy Clayton, M.D. Vice Chair Clinical Practice and Quality Department of Laboratory Medicine and Pathology Mayo Clinic, Rochester MN Notice of Faculty Disclosure
HOW TO APPLY FOR MEDICAL DEVICE REGISTRATION UNDER MEDICAL DEVICE ACT 2012 (ACT 737)
MDA/GL No 1: July 2013 Guidelines for implementation of medical device regulatory system HOW TO APPLY FOR MEDICAL DEVICE REGISTRATION UNDER MEDICAL DEVICE ACT 2012 (ACT 737) [Appendix 4 Schedule 3 Medical
Global In-Vitro Diagnostic Market Report
Global In-Vitro Diagnostic Market Report ----------------------------------------------------- 2013 Executive Summary The process of performing a diagnostic test outside of a living organism in an artificial
APPENDIX C SURVEY PROCEDURES AND INTERPRETIVE GUIDELINES FOR LABORATORIES AND LABORATORY SERVICES
APPENDIX C SURVEY PROCEDURES AND INTERPRETIVE GUIDELINES FOR LABORATORIES AND LABORATORY SERVICES SURVEY PROCEDURES AND INTERPRETIVE GUIDELINES FOR LABORATORIES AND LABORATORY SERVICES Part 1 Policy for
Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities
Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities Introduction The report analyzes current and potential world molecular diagnostics markets and advances in the field.
PRESENT ON ADMISSION (POA)
PRESENT ON ADMISSION (POA) What does Present on Admission (POA) stand for? POA is defined as a diagnosis present at the time the order for inpatient admission occurs. The POA indicator is to differentiate
Value Cycle Excellence: Chargemaster Management for Multi-Hospital Health Systems
Sponsored By: Value Cycle Excellence: Chargemaster Management for Multi-Hospital Health Systems Tuesday, October 4, 2016 Noon 1:00 Pacific / 1:00 2:00 Mountain / 2:00 3:00 Central / 3:00-4:00 PM Eastern
Coding Compliance Reimbursement Products. Call Now
Coding Compliance Reimbursement Products CPT Case Studies Book Free with orders over $200 See page 22 NEW 2018 FEES Since 1983 the PFR is the original and most widely used physicians fee guide on the market
ICD-10 Trends Real Talk OBJECTIVES: Disclaimers FHIMA 6/8/2016. KYoumans 1. Karen Youmans, MPA, RHIA, CCS President, YES HIM Consulting, Inc.
ICD-10 Trends Real Talk Karen Youmans, MPA, RHIA, CCS President, YES HIM Consulting, Inc. OBJECTIVES: At the end of this session, the attendee will be able to: Discuss coder productivity under ICD-10-CM/PCS
Coding Systems Understanding NDC and HCPCS
Coding Systems Understanding NDC and HCPCS National Drug Code The National Drug Code (NDC) serves as a universal product identifier for prescription medications approved for human consumption. According
The Centers for Medicare and Medicaid Services (CMS) will hold
Celebrating Our 32nd Year of Publication Vol. 11, Iss. 12, June 23, 2011 CMS Sets July Date for Medicare Lab Test Pricing Forum This is the first step in the annual process, required by law, to get public
Medidée Services SA. Nano-Tera.ch. 05 February 2015 part 8. PMA, 510k, IDE. Pierre-Alain Sommer
Nano-Tera.ch 05 February 2015 part 8 PMA, 510k, IDE Pierre-Alain Sommer Pierre-alain.sommer@medidee.com www.medidee.com Nano-Tera 2015 05.02.2015 USA/FDA Pre Market Approval System - PMA, Pre Market Notifcation
SPECIMEN INFORMATION PATIENT INFORMATION REFERRING PROVIDER INFORMATION. Institution: Same as Referring Provider
The LMM is a satellite facility of Massachusetts General Hospital. CLIA # 22D1005307 Specimen (Refer to page 4 for Specimen and Shipping requirements): SPECIMEN INFORMATION Blood (5-7mL K 2 EDTA/K 3 EDTA)
BlueOptions Prime Plus Plan
BlueOptions Prime Plus Plan Schedule of Benefits Plan 03766 Important things to keep in mind as you review this Schedule of Benefits: This Schedule of Benefits is part of your Benefit Booklet, where more
Completing the performance picture.
Completing the performance picture. AU5800 Clinical Chemistry Systems Blood Banking Centrifugation Chemistry Flow Cytometry Hematology Hemostasis Immunoassay Information Systems Lab Automation Molecular
The Value of Diagnostics Innovation, Adoption and Diffusion into Health Care
Innovation, Adoption and Diffusion into Health Care Prepared for: AdvaMed Prepared by: The Lewin Group, Inc. July 2005 Innovation, Adoption and Diffusion into Health Care Prepared for: AdvaMed Prepared
Survey of Neural Networks in Digital Pathology and Pathology Workflow
Survey of Neural Networks in Digital Pathology and Pathology Workflow Christianne Dinsmore 1 1 Department of Computing and Digital Media DePaul University Chicago, IL Abstract Digital pathology has already
BSc BIOMEDICAL SCIENCE
Overview College of Science Biomedical Science Core March 2017 (1) BSc BIOMEDICAL SCIENCE Biomedical Science Degree 2015 1 College of Science, NUI Galway Fullscreen Next page Overview [60 credits] [60
This is a licensed product of Ken Research and should not be copied
1 TABLE OF CONTENTS 1. India In-Vitro Diagnostics Market Introduction Market Overview Growth Drivers Constraints Regulatory Framework and Accreditation 2. India In-Vitro Diagnostics Market Size by Revenues,
Flexible, robust solutions from BSI. An In Vitro Diagnostic Notified Body. Expertise and experience. IVD regulatory solutions
Flexible, robust solutions from BSI An In Vitro Diagnostic Notified Body Expertise and experience IVD regulatory solutions Updated May 2017 Your guide to the In Vitro Diagnostic Directive The purpose of
CODING GUIDELINES. Radiation Therapy. Effective January 1, 2018
CODING GUIDELINES Radiation Therapy Effective January 1, 2018 Coding guidelines for medical necessity review of radiation therapy services. 2018 evicore healthcare. All rights reserved. Please note the
Handouts 4/5/2016. BCA Members willing to genotype your samples on Immucor PreciseType HEA
BCA Members willing to genotype your samples on Immucor PreciseType HEA Community Blood Center - Dayton Blood Bank of Delmarva Indiana Blood Center LifeServe Blood Center LifeShare Blood Centers LifeSouth
Doctor of Pharmacy Course Descriptions
Doctor of Pharmacy Course Descriptions Required Courses Pharmacy Practicum II (7002) Second practicum with direct instruction by an experienced preceptor to increase the student's awareness of the pharmacist's
Diagnosis for Open Wounds as a Result of Cancer Resection
Diagnosis for Open Wounds as a Result of Cancer Resection December 15, 2016 What diagnosis code do we use when we are reconstructing a defect after the Moh s surgeon, or someone else removed the cancer?
Automated Method for Determination of Infectious Dose (TCID 50 ) using Celigo Imaging Cytometer
Automated Method for Determination of Infectious Dose (TCID 50 ) using Celigo Imaging Cytometer Nexcelom Bioscience LLC. 360 Merrimack Street, Building 9 Lawrence, MA 01843 T: 978.327.5340 F: 978.327.5341
The China In Vitro Diagnostics (IVD) Market has been analyzed from 4 View Points:
China In Vitro Diagnostics (IVD) Market - Overview China In-Vitro Diagnostics (IVD) market is among the fastest growing in the world. It is anticipated that China IVD market will more than triple by 2020
Clinical Laboratory Consultants and Contacts January 2018
DEPARTMENT PAGE Administration 1 Autopsy 2 Bone Marrow 2 Client Services 2 Core Laboratory 3 Cytopathology 3 Dermatopathology 3 Flow Cytometry 4 HLA 4 Immunology 4 Laboratory Information Systems Support
Integrated Radiology & Pathology Diagnostic Services: The Time is Now at UCLA
Integrated Radiology & Pathology Diagnostic Services: The Time is Now at UCLA Scott W Binder MD Pritzker Professor of Clinical Pathology and Dermatology Senior Vice Chair Director, Pathology Clinical Services
Key changes in new BCSH Transfusion I.T. Guidelines. Debbie Asher EPA Network Transfusion Manager Member, BCSH Guideline Writing Group
Key changes in new BCSH Transfusion I.T. Guidelines Debbie Asher EPA Network Transfusion Manager Member, BCSH Guideline Writing Group Membership Joan Jones Head of Quality, Welsh Blood Service Paul Ashford
Miramont Family Medicine
Miramont Family Medicine Adopted the Patient Centered Medical Home model to provide highest-quality, lowest-cost services to our patients Physician Owned Laboratory (POL) integral to delivery of our health
Cyfra 21-1 IRMA. Product information Information about other products is available at: Userś Manual DE52100
Product information Information about other products is available at: www.demeditec.com Userś Manual Cyfra 21-1 IRMA The CYFRA 21.1 IRMA system provides a direct in vitro quantitative determination of
Strategies for Assessment of Immunotoxicology in Preclinical Drug Development
Strategies for Assessment of Immunotoxicology in Preclinical Drug Development Rebecca Brunette, PhD Scientist, Analytical Biology SNBL USA Preclinical Immunotoxicology The study of evaluating adverse effects
13 15 SEPTEMBER 2017 SERVING LABORATORY MANAGEMENT & DIOGNOSTIC NETWORKS GLOBALLY BARCELONA CONGRESS CENTRE, BARCELONA, SPAIN
13 15 SEPTEMBER 2017 BARCELONA CONGRESS CENTRE, BARCELONA, SPAIN SERVING LABORATORY MANAGEMENT & DIOGNOSTIC NETWORKS GLOBALLY www.medlabeurope.com medlabeurope@informa.com +34 518890041 INTRODUCTION It
Blood Product Utilization
Who gets what & when Why not to give blood? Volume Expander For specific number (except as related to procedures) To patients with religious objections to blood transfusions Blood given only when necessary
Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations. Audrey Chang, PhD, Senior Director Development Services
Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations Audrey Chang, PhD, Senior Director Development Services Definition of Biologics: PHS Act, section 351 Virus, therapeutic
Students enrolled in the MLT program will have the opportunity to participate in the MLT Club on campus.
Medical Technology Dr. Karen Escolas, Chair Medical Laboratory Technology Dept. Karen.Escolas@farmingdale.edu 631-420-2257 School of Health Sciences Bachelor of Science Degree The BS program in Medical
Radiography Curriculum Analysis
Program Number Program Name Date / /20 Radiography Curriculum Analysis DIRECTIONS: Determine the course(s) in which each of the following content area is covered and enter the course number(s) and/or title(s).
The Role of Standards in U.S. FDA Regulation of Cellular Therapy Products
The Role of Standards in U.S. FDA Regulation of Cellular Therapy Products Judith Arcidiacono M.S. International Regulatory Expert Standards Development Activities Liaison U.S. Food and Drug Administration
Eliminating Infusion Confusion
Eliminating Infusion Confusion (Drug Administrations in Non-facility Settings) Maryann C. Palmeter, CPC, CENTC Agenda Review of CPT codes (added in 2009) Documentation principles Key definitions What s
April 15, 2015 VIA ELECTRONIC MAIL
April 15, 2015 VIA ELECTRONIC MAIL Patricia Brooks, RHIA Senior Technical Advisor Centers for Medicare and Medicaid Services Hospital and Ambulatory Policy Group Mail Stop C4-08-06 7500 Security Boulevard
Digital Cytopathology & Interactive Case Discussion
Digital Cytopathology & Interactive Case Discussion Marilyn M. Bui, MD, PhD Senior Member & Scientific Director of Analytic Microscopy Core Section Head, Bone and Soft Tissue Pathology Program Leader,
TEST REQUISITION, PATIENT INFORMATION, AND CONSENT HUDSONALPHA CLINICAL SERVICES LABORATORY
1. Patient Information Patient Name TEST REQUISITION, PATIENT INFORMATION, AND CONSENT HUDSONALPHA CLINICAL SERVICES LABORATORY HudsonAlpha Clinical Services Lab, LLC HUDSONALPHA CLINICAL SERVICES LABORATORY
With its passage of. Competitive Bidding. The Coming of. for Medicare DME Reimbursement
The Coming of Competitive Bidding for Medicare DME Reimbursement Suppliers of durable medical equipment must go toe-to-toe on price. Will manufacturers be just interested bystanders? Jesse A. Witten and